UniProt ID | RSBNL_HUMAN | |
---|---|---|
UniProt AC | Q6PCB5 | |
Protein Name | Round spermatid basic protein 1-like protein | |
Gene Name | RSBN1L | |
Organism | Homo sapiens (Human). | |
Sequence Length | 846 | |
Subcellular Localization | Nucleus. | |
Protein Description | ||
Protein Sequence | MAEPPSPVHCVAAAAPTATVSEKEPFGKLQLSSRDPPGSLSAKKVRTEEKKAPRRVNGEGGSGGNSRQLQPPAAPSPQSYGSPASWSFAPLSAAPSPSSSRSSFSFSAGTAVPSSASASLSQPVPRKLLVPPTLLHAQPHHLLLPAAAAAASANAKSRRPKEKREKERRRHGLGGAREAGGASREENGEVKPLPRDKIKDKIKERDKEKEREKKKHKVMNEIKKENGEVKILLKSGKEKPKTNIEDLQIKKVKKKKKKKHKENEKRKRPKMYSKSIQTICSGLLTDVEDQAAKGILNDNIKDYVGKNLDTKNYDSKIPENSEFPFVSLKEPRVQNNLKRLDTLEFKQLIHIEHQPNGGASVIHAYSNELSHLSPMEMERFAEEFVGLVFSENENSAAFYVMGIVHGAATYLPDFLDYFSFNFPNSPVKMEILGKKDIETTTMSNFHAQVKRTYSHGTYRAGPMRQISLVGAVDEEVGDYFPEFLDMLEESPFLKCTLPWGTLSSLKLQSRKDSDDGPIMWVRPGEQMIPVADMPKSPFKRKRTTNEIKNLQYLPRTSEPREMLFEDRTRAHADHIGQGFERQTTAAVGVLKAVHCGEWPDQPRITKDVICFHAEDFLEVVQRMQLDLHEPPLSQCVQWVDDAKLNQLRREGIRYARIQLYDNDIYFIPRNVVHQFKTVSAVCSLAWHIRLKLYHSEEDTSQNTATHETGTSSDSTSSVLGPHTDNMICAVSKASLDSVFSDKLHSKYELQQIKHEPIASVRIKEEPVNVNIPEKTTALNNMDGKNVKAKLDHVQFAEFKIDMDSKFENSNKDLKEELCPGNLSLVDTRQHSSAHSNQDKKDDDILC | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAEPPSPVH ------CCCCCCCCC | 37.69 | 19413330 | |
6 | Phosphorylation | --MAEPPSPVHCVAA --CCCCCCCCCEEEE | 50.71 | 29255136 | |
17 | Phosphorylation | CVAAAAPTATVSEKE EEEECCCCCEECCCC | 30.18 | 20068231 | |
19 | Phosphorylation | AAAAPTATVSEKEPF EECCCCCEECCCCCC | 27.35 | 20068231 | |
21 | Phosphorylation | AAPTATVSEKEPFGK CCCCCEECCCCCCCC | 38.30 | 20068231 | |
28 | Acetylation | SEKEPFGKLQLSSRD CCCCCCCCCCCCCCC | 33.18 | 19608861 | |
32 | Phosphorylation | PFGKLQLSSRDPPGS CCCCCCCCCCCCCCC | 15.46 | 25159151 | |
33 | Phosphorylation | FGKLQLSSRDPPGSL CCCCCCCCCCCCCCC | 49.66 | - | |
39 | Phosphorylation | SSRDPPGSLSAKKVR CCCCCCCCCCCCCCC | 25.56 | 21815630 | |
41 | Phosphorylation | RDPPGSLSAKKVRTE CCCCCCCCCCCCCCC | 39.48 | 21815630 | |
43 | Acetylation | PPGSLSAKKVRTEEK CCCCCCCCCCCCCCC | 48.72 | 25953088 | |
44 | Ubiquitination | PGSLSAKKVRTEEKK CCCCCCCCCCCCCCC | 36.34 | 24816145 | |
44 | Acetylation | PGSLSAKKVRTEEKK CCCCCCCCCCCCCCC | 36.34 | 11924383 | |
51 | Ubiquitination | KVRTEEKKAPRRVNG CCCCCCCCCCCCCCC | 67.89 | 24816145 | |
62 | Phosphorylation | RVNGEGGSGGNSRQL CCCCCCCCCCCCCCC | 55.15 | 27174698 | |
76 | Phosphorylation | LQPPAAPSPQSYGSP CCCCCCCCCCCCCCC | 30.74 | 22199227 | |
79 | Phosphorylation | PAAPSPQSYGSPASW CCCCCCCCCCCCCCC | 34.54 | 22199227 | |
80 | Phosphorylation | AAPSPQSYGSPASWS CCCCCCCCCCCCCCC | 19.17 | 22199227 | |
82 | Phosphorylation | PSPQSYGSPASWSFA CCCCCCCCCCCCCCC | 14.73 | 22199227 | |
85 | Phosphorylation | QSYGSPASWSFAPLS CCCCCCCCCCCCCCC | 27.00 | 22199227 | |
87 | Phosphorylation | YGSPASWSFAPLSAA CCCCCCCCCCCCCCC | 14.72 | 22199227 | |
92 | Phosphorylation | SWSFAPLSAAPSPSS CCCCCCCCCCCCCCC | 22.71 | 22199227 | |
92 | O-linked_Glycosylation | SWSFAPLSAAPSPSS CCCCCCCCCCCCCCC | 22.71 | 23301498 | |
96 | Phosphorylation | APLSAAPSPSSSRSS CCCCCCCCCCCCCCC | 32.46 | 22199227 | |
96 | O-linked_Glycosylation | APLSAAPSPSSSRSS CCCCCCCCCCCCCCC | 32.46 | 23301498 | |
98 | O-linked_Glycosylation | LSAAPSPSSSRSSFS CCCCCCCCCCCCCEE | 45.33 | 23301498 | |
98 | Phosphorylation | LSAAPSPSSSRSSFS CCCCCCCCCCCCCEE | 45.33 | 22199227 | |
99 | Phosphorylation | SAAPSPSSSRSSFSF CCCCCCCCCCCCEEE | 32.91 | 19690332 | |
99 | O-linked_Glycosylation | SAAPSPSSSRSSFSF CCCCCCCCCCCCEEE | 32.91 | 23301498 | |
100 | O-linked_Glycosylation | AAPSPSSSRSSFSFS CCCCCCCCCCCEEEE | 40.28 | 23301498 | |
100 | Phosphorylation | AAPSPSSSRSSFSFS CCCCCCCCCCCEEEE | 40.28 | 22199227 | |
102 | Phosphorylation | PSPSSSRSSFSFSAG CCCCCCCCCEEEECC | 37.37 | 25159151 | |
102 | O-linked_Glycosylation | PSPSSSRSSFSFSAG CCCCCCCCCEEEECC | 37.37 | 23301498 | |
103 | Phosphorylation | SPSSSRSSFSFSAGT CCCCCCCCEEEECCC | 24.65 | 25159151 | |
103 | O-linked_Glycosylation | SPSSSRSSFSFSAGT CCCCCCCCEEEECCC | 24.65 | 23301498 | |
105 | Phosphorylation | SSSRSSFSFSAGTAV CCCCCCEEEECCCCC | 21.90 | 26434776 | |
107 | Phosphorylation | SRSSFSFSAGTAVPS CCCCEEEECCCCCCC | 25.29 | 27080861 | |
110 | Phosphorylation | SFSFSAGTAVPSSAS CEEEECCCCCCCCCC | 24.97 | 27080861 | |
115 | O-linked_Glycosylation | AGTAVPSSASASLSQ CCCCCCCCCCCCCCC | 21.85 | 23301498 | |
183 | Phosphorylation | AREAGGASREENGEV HHHCCCCCHHCCCCC | 43.42 | 26714015 | |
191 | Acetylation | REENGEVKPLPRDKI HHCCCCCCCCCHHHH | 36.21 | 23749302 | |
191 | Ubiquitination | REENGEVKPLPRDKI HHCCCCCCCCCHHHH | 36.21 | 24816145 | |
201 | Ubiquitination | PRDKIKDKIKERDKE CHHHHHHHHHHHHHH | 51.15 | 24816145 | |
223 | Sumoylation | HKVMNEIKKENGEVK HHHHHHHHHHCCCEE | 48.10 | 28112733 | |
235 | Phosphorylation | EVKILLKSGKEKPKT CEEEEEECCCCCCCC | 55.88 | 24505115 | |
250 | Ubiquitination | NIEDLQIKKVKKKKK CHHHHHHHHHHHHHH | 38.25 | 29967540 | |
250 | Acetylation | NIEDLQIKKVKKKKK CHHHHHHHHHHHHHH | 38.25 | 25953088 | |
251 | Ubiquitination | IEDLQIKKVKKKKKK HHHHHHHHHHHHHHH | 62.00 | - | |
273 | Phosphorylation | RKRPKMYSKSIQTIC HHCHHHHHHHHHHHH | 19.21 | 24719451 | |
278 (in isoform 2) | Ubiquitination | - | 23.45 | 21890473 | |
278 | Phosphorylation | MYSKSIQTICSGLLT HHHHHHHHHHHCCCC | 23.45 | 27690223 | |
278 | Ubiquitination | MYSKSIQTICSGLLT HHHHHHHHHHHCCCC | 23.45 | 21890473 | |
281 | Phosphorylation | KSIQTICSGLLTDVE HHHHHHHHCCCCCHH | 28.73 | 26552605 | |
285 | Phosphorylation | TICSGLLTDVEDQAA HHHHCCCCCHHHHHH | 42.94 | 27422710 | |
301 | Ubiquitination | GILNDNIKDYVGKNL HHCCHHHHHHCCCCC | 49.62 | 29967540 | |
303 | Phosphorylation | LNDNIKDYVGKNLDT CCHHHHHHCCCCCCC | 13.19 | 30576142 | |
306 | Acetylation | NIKDYVGKNLDTKNY HHHHHCCCCCCCCCC | 44.27 | 25953088 | |
306 | Ubiquitination | NIKDYVGKNLDTKNY HHHHHCCCCCCCCCC | 44.27 | 29967540 | |
313 | Phosphorylation | KNLDTKNYDSKIPEN CCCCCCCCCCCCCCC | 24.13 | 23186163 | |
315 | Phosphorylation | LDTKNYDSKIPENSE CCCCCCCCCCCCCCC | 23.33 | 28112733 | |
321 | Phosphorylation | DSKIPENSEFPFVSL CCCCCCCCCCCCCCC | 38.66 | 23186163 | |
327 | Phosphorylation | NSEFPFVSLKEPRVQ CCCCCCCCCCCHHHH | 33.82 | 28555341 | |
329 | Acetylation | EFPFVSLKEPRVQNN CCCCCCCCCHHHHCC | 59.16 | 23236377 | |
329 | Ubiquitination | EFPFVSLKEPRVQNN CCCCCCCCCHHHHCC | 59.16 | 29967540 | |
338 | Acetylation | PRVQNNLKRLDTLEF HHHHCCHHCCCEEEE | 53.70 | 25953088 | |
342 | Phosphorylation | NNLKRLDTLEFKQLI CCHHCCCEEEEHHHE | 32.55 | 24247654 | |
440 | Phosphorylation | GKKDIETTTMSNFHA CCCCCEECCCCCCHH | 14.01 | 20068231 | |
450 | Acetylation | SNFHAQVKRTYSHGT CCCHHEEEECCCCCC | 27.26 | 7710369 | |
457 | Phosphorylation | KRTYSHGTYRAGPMR EECCCCCCEECCCCE | 12.38 | - | |
458 | Phosphorylation | RTYSHGTYRAGPMRQ ECCCCCCEECCCCEE | 11.76 | - | |
490 | Phosphorylation | FLDMLEESPFLKCTL HHHHHHHCCCCEEEC | 16.15 | 26074081 | |
496 | Phosphorylation | ESPFLKCTLPWGTLS HCCCCEEECCCCCHH | 33.98 | 26074081 | |
501 | Phosphorylation | KCTLPWGTLSSLKLQ EEECCCCCHHHEEEC | 21.43 | 26074081 | |
503 | Phosphorylation | TLPWGTLSSLKLQSR ECCCCCHHHEEECCC | 33.20 | 26074081 | |
504 | Phosphorylation | LPWGTLSSLKLQSRK CCCCCHHHEEECCCC | 32.41 | 26699800 | |
506 | Ubiquitination | WGTLSSLKLQSRKDS CCCHHHEEECCCCCC | 46.56 | - | |
509 | Phosphorylation | LSSLKLQSRKDSDDG HHHEEECCCCCCCCC | 52.30 | 26074081 | |
536 | Phosphorylation | PVADMPKSPFKRKRT ECCCCCCCCCCCCCC | 29.69 | 25159151 | |
548 | Ubiquitination | KRTTNEIKNLQYLPR CCCCHHHCCCCCCCC | 45.48 | 23000965 | |
548 (in isoform 1) | Ubiquitination | - | 45.48 | 21890473 | |
548 | Sumoylation | KRTTNEIKNLQYLPR CCCCHHHCCCCCCCC | 45.48 | 28112733 | |
552 | Phosphorylation | NEIKNLQYLPRTSEP HHHCCCCCCCCCCCC | 23.11 | 25003641 | |
557 | Phosphorylation | LQYLPRTSEPREMLF CCCCCCCCCCHHHHH | 47.05 | 28555341 | |
734 | Phosphorylation | ICAVSKASLDSVFSD EEEEEHHHHHHHHHH | 36.12 | 23663014 | |
742 | Acetylation | LDSVFSDKLHSKYEL HHHHHHHHHHCCCCH | 47.07 | 25953088 | |
746 | Acetylation | FSDKLHSKYELQQIK HHHHHHCCCCHHHCC | 31.81 | 25953088 | |
746 | Ubiquitination | FSDKLHSKYELQQIK HHHHHHCCCCHHHCC | 31.81 | 29967540 | |
753 | Sumoylation | KYELQQIKHEPIASV CCCHHHCCCCCCEEE | 37.26 | 28112733 | |
753 | Sumoylation | KYELQQIKHEPIASV CCCHHHCCCCCCEEE | 37.26 | - | |
763 | Sumoylation | PIASVRIKEEPVNVN CCEEEEEEECCCCCC | 45.52 | - | |
763 | Sumoylation | PIASVRIKEEPVNVN CCEEEEEEECCCCCC | 45.52 | 28112733 | |
774 | Acetylation | VNVNIPEKTTALNNM CCCCCCCCCCCCCCC | 45.91 | 25953088 | |
784 | Acetylation | ALNNMDGKNVKAKLD CCCCCCCCCCEEECC | 55.06 | 25953088 | |
789 | Acetylation | DGKNVKAKLDHVQFA CCCCCEEECCEEEEE | 49.05 | 25953088 | |
814 | Sumoylation | ENSNKDLKEELCPGN CCCCHHHHHHHCCCC | 60.31 | - | |
814 | Sumoylation | ENSNKDLKEELCPGN CCCCHHHHHHHCCCC | 60.31 | 28112733 | |
823 | Phosphorylation | ELCPGNLSLVDTRQH HHCCCCCEEEECCCC | 30.28 | 21815630 | |
827 | Phosphorylation | GNLSLVDTRQHSSAH CCCEEEECCCCCCCC | 25.42 | 20068231 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RSBNL_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RSBNL_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RSBNL_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RSBN1_HUMAN | RSBN1 | physical | 28514442 | |
PININ_HUMAN | PNN | physical | 28514442 | |
CLK2_HUMAN | CLK2 | physical | 28514442 | |
SRRM2_HUMAN | SRRM2 | physical | 28514442 | |
NKAP_HUMAN | NKAP | physical | 28514442 | |
RNPS1_HUMAN | RNPS1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-6, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-28, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-6, AND MASS SPECTROMETRY. |